Life sciences venture capitalists will discuss opportunities they’re finding in early-stage biotech and medical devices companies, despite what seems to be a dropoff in funding, at this MIT Enterprise Forum of Cambridge-hosted discussion. They’ll also be sharing which life sciences and healthcare technologies they find most promising. You can register for this one here.